Yu, Haixiang
Kumar, Shekhar
Frederiksen, James W.
Kolyadko, Vladimir N. http://orcid.org/0000-0003-4008-2461
Pitoc, George
Layzer, Juliana
Yan, Amy
Rempel, Rachel
Francis, Samuel http://orcid.org/0000-0003-3210-0789
Krishnaswamy, Sriram
Sullenger, Bruce A.
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P01-HL139420)
American Heart Association (23POST1018721)
Article History
Received: 20 December 2023
Accepted: 22 April 2024
First Online: 10 May 2024
Competing interests
: Duke has submitted a patent application (U.S. Provisional Application No. 63/421,756) on the thrombin and factor Xa EXACT inhibitors. H.Y. and B.A.S. are inventors on such Duke Intellectual Property. The remaining authors declare no competing interests.
: This research complies with ethical regulations under Duke University Health System (DUHS) Institutional Review Board for Clinical Investigations with Federal wide Assurance No: FWA 00009025